Non-leukemic HSPCs from CP-CML patients showed dysregulation of inflammatory TNF-alpha and TNF-beta pathways, associated with increased SC quiescence and a possible disruption of the CML microenvironment. The gene discussed is LTA; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.